Globus Medical - Asset Resilience Ratio

Latest as of June 2026: 1.59%

Globus Medical (GMED) has an Asset Resilience Ratio of 1.59% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Globus Medical working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

$87.40 Million
Cash + Short-term Investments

Total Assets

$5.49 Billion
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2012–2025)

This chart shows how Globus Medical's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Globus Medical.

Liquid Assets Composition Over Time

This chart breaks down Globus Medical's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Globus Medical long-term investment allocation to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $87.40 Million 1.59%
Total Liquid Assets $87.40 Million 1.59%

Asset Resilience Insights

  • Limited Liquidity: Globus Medical maintains only 1.59% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Globus Medical Industry Peers by Asset Resilience Ratio

Compare Globus Medical's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.84%
Shandong Weigao Orthopaedic Device Co. Ltd. A
SHG:688161
Medical Devices 6.28%
Jafron Biomedical Co Ltd
SHE:300529
Medical Devices 34.37%
Ningbo David Medical Device Co Ltd
SHE:300314
Medical Devices 5.11%
Beijing Succeeder Technology Inc
SHG:688338
Medical Devices 28.27%
Dirui Industrial Co Ltd
SHE:300396
Medical Devices 3.90%
Profound Medical Corp
TO:PRN
Medical Devices 67.66%
Affluent Medical SAS
PA:AFME
Medical Devices 0.03%

Annual Asset Resilience Ratio for Globus Medical (2012–2025)

The table below shows the annual Asset Resilience Ratio data for Globus Medical.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.59% $31.09 Million $5.30 Billion -1.42pp
2024-12-31 2.01% $105.62 Million $5.25 Billion +1.02pp
2023-12-31 0.99% $50.50 Million $5.09 Billion -13.24pp
2022-12-31 14.24% $295.59 Million $2.08 Billion +1.45pp
2021-12-31 12.79% $250.38 Million $1.96 Billion +1.64pp
2020-12-31 11.15% $187.34 Million $1.68 Billion +3.60pp
2019-12-31 7.56% $115.76 Million $1.53 Billion -7.82pp
2018-12-31 15.37% $199.94 Million $1.30 Billion -8.26pp
2017-12-31 23.63% $254.89 Million $1.08 Billion -0.44pp
2016-12-31 24.08% $223.36 Million $927.64 Million -2.40pp
2015-12-31 26.48% $220.88 Million $834.10 Million +5.67pp
2014-12-31 20.81% $146.44 Million $703.55 Million -5.49pp
2013-12-31 26.30% $148.96 Million $566.30 Million --
2012-12-31 0.00% $0.00 $447.13 Million --
pp = percentage points

About Globus Medical

NYSE:GMED USA Medical Devices
Market Cap
$8.39 Billion
Market Cap Rank
#2562 Global
#930 in USA
Share Price
$74.08
Change (1 day)
-0.11%
52-Week Range
$55.10 - $96.82
All Time High
$96.82
About

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting… Read more